Advertisement
 
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Daiichi Sankyo Submits Edoxaban NDA

April 9, 2010 6:13 am | News | Comments

Daiichi Sankyo Company, Limited announced that it has submitted a New Drug Application to in Japan seeking approval of the anticoagulant, edoxaban, for the prevention of venous thromboembolism (VTE) after major orthopedic surgery.

TOPICS:

Peptide Allows Deeper Tumor Penetration

April 9, 2010 6:07 am | News | Comments

Researchers have shown that a peptide called iRGD helps co-administered drugs penetrate deeply into tumor tissue. The peptide has been shown to substantially increase treatment efficacy against human breast, prostate, and pancreatic cancers in mice.

TOPICS:

Autism Study Finds Possible Drug Target

April 9, 2010 6:03 am | News | Comments

A new discovery raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought.

TOPICS:
Advertisement

New Method Allows Scientists To Probe Gene Activation

April 9, 2010 5:59 am | News | Comments

NYU Langone Medical Center researchers have developed a powerful new method to investigate the discrete steps necessary to turn on individual genes and examine how the process goes wrong in cancer and other diseases.

TOPICS:

Hepatitis C Doubles Risk of Kidney Cancer

April 9, 2010 5:54 am | News | Comments

Physicians found that from 1997-2008, 0.6% of patients with hepatitis C infection developed kidney cancer whereas only 0.3% patients without the disease developed kidney cancer.

TOPICS:

Nanoparticle Vaccine Cures Type 1 Diabetes

April 9, 2010 5:51 am | News | Comments

Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease.

TOPICS:

Compound Destroys Antibiotic-Resistant Biofilms

April 9, 2010 5:46 am | News | Comments

Researchers at North Carolina State University have found a chemical compound that, when used in conjunction with conventional antibiotics, is effective in destroying biofilms produced by antibiotic-resistant strains of bacteria such as the Staphylococcus strain MRSA.

TOPICS:

Sanofi And CureDM to Develop Diabetes Treatment

April 9, 2010 5:41 am | News | Comments

Sanofi-Aventis and CureDM Group Holdings LLC will work to develop a diabetes treatment aimed at restoring a patient's ability to produce insulin and other pancreatic hormones.

TOPICS:
Advertisement

FDA Reviewing Triclosan Usage

April 9, 2010 5:37 am | News | Comments

The Food and Drug Administration is reviewing the safety of a widely used chemical found in antibacterial soap, toothpaste and other consumer goods.

TOPICS:

LC/MS Solvents

April 8, 2010 6:25 am | Product Releases | Comments

Mallinckrodt Baker’s J.T.Baker ULTRA Liquid Chromatography/Mass Spectrometry solvents are designed for the most demanding ultra-high pressure liquid chromatography and mass spectrometry research and analytical testing applications.

TOPICS:

Microscope Automation System

April 8, 2010 6:09 am | Product Releases | Comments

Prior Scientific introduces a significant advancement in microscope automation control - the ProScan III Microscope Automation System.

TOPICS:

Chromatography Data System

April 8, 2010 6:03 am | Product Releases | Comments

Thermo Fisher Scientific Inc. announced the availability of a Thermo Scientific Atlas Chromatography Data System integration solution for Symyx Technologies' electronic laboratory notebook.

TOPICS:

Mallinckrodt Baker Introduces New Grade of Acetonitrile

April 8, 2010 5:58 am | News | Comments

Mallinckrodt Baker, a business unit of Covidien, a global provider of healthcare products, has introduced a new grade of acetonitrile to match the quality requirements for customers performing routine high-performance liquid chromatography applications and analysis.

TOPICS:

ISICR Accepting Nominees for Milstein Prize

April 8, 2010 5:53 am | News | Comments

At the Annual Meeting of the International Society of Interferon and Cytokine Research, the Milstein Prize will be bestowed upon a leading biomedical research scientist who has made outstanding contributions to research related to interferons and cytokines.

TOPICS:

Sumatriptan Performs Well in Phase 2 Trial

April 8, 2010 5:45 am | News | Comments

OptiNose, a maker of nasal drug delivery systems, has announced the publication in Cephalalgia of results from its Phase 2 clinical study investigating the efficacy and tolerability of its novel, intranasal drug/device product for the treatment of migraine.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading